Latest Period
Q2 2026
Security Snapshot
CVRx, Inc. - Common Stock, $0.01 par value (CVRX) Institutional Ownership
CUSIP: 126638105
13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026
Institutions Reporting
87
Shares (Excl. Options)
15,261,492
Price
$5.14
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.01 par value
- Symbol
- CVRX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 15,261,492
- Total 13F value
- $78,464,784
- Portfolio coverage rank
- 0%
- Share change
- +596,820
- Value change
- -$2,978,352
- Number of holders
- 87
- Shares outstanding
- 26,577,273
- SEC-reported price per share
- $5.38
- Insider filing price
- $5.38
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CVRX - CVRx, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 126638105.
- 87 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 98 to 87 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $138,937,436 to $78,464,784.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 87 institutions filings for Q2 2026.
Security key
126638105
Latest holder period
Q2 2026
13F holders
87
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
CVRX full holder history
CVRx, Inc. SEC filings
CVRx, Inc. company facts
CVRx, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 126638105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
CVRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15% | $28,578,928 | 4,024,861 | JOHNSON & JOHNSON | 31 Dec 2025 | |||
| NEW ENTERPRISE ASSOCIATES 10 L P | 7.8% | $13,635,539 | 2,026,083 | New Enterprise Associates 10, Limited Partnership | 18 Feb 2025 | |||
| Vensana Capital I GP, LLC | 7.2% | $11,849,740 | 1,760,734 | Kirk Nielsen | 31 Dec 2024 | |||
| Chernett Jorey | 5.5% | 0% | $7,864,215 | 1,461,750 | 0% | Chernett Jorey | 24 Aug 2026 | |
| Cooperatieve Gilde Healthcare IV U.A. | 4.9% | $8,287,928 | 1,231,490 | Cooperatieve Gilde Healthcare IV U.A. | 04 Feb 2025 |
As of 30 Jun 2026, 87 institutional investors reported holding 15,261,492 shares of CVRx, Inc. - Common Stock, $0.01 par value (CVRX). This represents 57% of the company’s total 26,577,273 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
55%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15% | 4,024,861 | 0% | 2.6% | $20,687,786 |
| NEA Management Company, LLC | 7.4% | 1,954,440 | -3.5% | 0.63% | $10,045,822 |
| BlackRock, Inc. | 4.7% | 1,245,459 | +21% | 0% | $6,401,661 |
| ROYAL BANK OF CANADA | 4.6% | 1,233,208 | +74% | 0% | $6,338,000 |
| GSK plc | 3.8% | 1,007,583 | 0% | 0.86% | $5,178,977 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 910,576 | -0.08% | 0% | $4,680,361 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 3.3% | 878,109 | +54% | 0.03% | $4,513,480 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 440,786 | +3.2% | 0% | $2,266,478 |
| PFM Health Sciences, LP | 1.4% | 369,572 | 0.16% | $1,899,600 | |
| STATE STREET CORP | 1.4% | 366,352 | +4.5% | 0% | $1,883,049 |
| RENAISSANCE TECHNOLOGIES LLC | 0.87% | 230,000 | +1092% | 0% | $1,182,200 |
| UBS Group AG | 0.84% | 224,233 | +116% | 0% | $1,152,558 |
| TUDOR INVESTMENT CORP ET AL | 0.77% | 205,684 | +4.2% | 0% | $1,057,216 |
| GOLDMAN SACHS GROUP INC | 0.56% | 149,509 | -26% | 0% | $768,476 |
| MORGAN STANLEY | 0.55% | 144,977 | +4% | 0% | $745,182 |
| Kestra Advisory Services, LLC | 0.5% | 132,400 | +176% | 0% | $680,536 |
| TWO SIGMA INVESTMENTS, LP | 0.5% | 132,398 | +16% | 0% | $680,526 |
| VANGUARD FIDUCIARY TRUST CO | 0.49% | 128,955 | +0.93% | 0% | $662,829 |
| DIMENSIONAL FUND ADVISORS LP | 0.48% | 127,971 | +143% | 0% | $659,866 |
| NORTHERN TRUST CORP | 0.47% | 124,767 | -17% | 0% | $641,302 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.4% | 105,915 | +12% | 0% | $544,403 |
| AQR CAPITAL MANAGEMENT LLC | 0.4% | 105,614 | +17% | 0% | $542,856 |
| Cresset Asset Management, LLC | 0.39% | 103,849 | -2.4% | 0% | $533,784 |
| BNP PARIBAS FINANCIAL MARKETS | 0.37% | 97,309 | 0% | 0% | $500,168 |
| Quantinno Capital Management LP | 0.31% | 82,333 | -29% | 0% | $423,192 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q2 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 15,261,492 | $78,464,784 | -$2,978,352 | $5.14 | 87 |
| 2026 Q1 | 14,691,674 | $138,937,436 | -$3,699,641 | $9.46 | 98 |
| 2025 Q4 | 15,210,504 | $108,000,876 | +$1,422,903 | $7.10 | 90 |
| 2025 Q3 | 14,003,450 | $113,001,810 | -$4,140,662 | $8.07 | 91 |
| 2025 Q2 | 14,566,804 | $85,403,778 | -$19,986,146 | $5.88 | 91 |
| 2025 Q1 | 15,971,769 | $195,337,855 | +$10,778,190 | $12.23 | 95 |
| 2024 Q4 | 15,154,273 | $192,128,165 | +$11,666,171 | $12.67 | 91 |
| 2024 Q3 | 14,208,138 | $125,172,924 | +$5,810,039 | $8.81 | 84 |
| 2024 Q2 | 13,192,379 | $158,176,281 | -$11,196,197 | $11.99 | 72 |
| 2024 Q1 | 13,441,680 | $244,665,057 | +$21,036,083 | $18.21 | 87 |
| 2023 Q4 | 12,015,323 | $377,446,209 | +$6,898,602 | $31.44 | 83 |
| 2023 Q3 | 11,953,961 | $181,343,253 | +$2,863,854 | $15.17 | 64 |
| 2023 Q2 | 11,594,427 | $179,048,989 | +$23,946,250 | $15.44 | 66 |
| 2023 Q1 | 10,400,213 | $96,928,042 | -$20,701,454 | $9.32 | 61 |
| 2022 Q4 | 10,299,118 | $188,989,468 | +$3,540,115 | $18.35 | 48 |
| 2022 Q3 | 10,529,611 | $98,240,851 | -$6,931,505 | $9.33 | 37 |
| 2022 Q2 | 10,888,954 | $65,444,210 | -$7,076,705 | $6.01 | 34 |
| 2022 Q1 | 12,073,187 | $72,317,176 | -$14,166,594 | $5.99 | 55 |
| 2021 Q4 | 12,884,491 | $157,579,777 | -$25,347,085 | $12.23 | 53 |
| 2021 Q3 | 11,758,612 | $194,426,346 | -$15,245,912 | $16.54 | 49 |
| 2021 Q2 | 13,787,189 | $386,044,000 | +$386,044,000 | $28.00 | 59 |